abstract |
The present disclosure relates to anti-IL-27 antibodies and antigen-binding portions thereof. The present disclosure also relates to a method of treating or ameliorating one or more symptoms of a disease, such as cancer, by administering an antibody or antigen-binding portion thereof. The disclosure also relates to methods of detecting IL-27, eg, in a subject or sample. |